Jill Rollet News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The FDA granted clearance for two new over-the-counter continuous glucose monitoring systems, one for adults with type 2 diabetes who do not use insulin and another for adults without diabetes, according to an industry press release. The FDA cleared the Abbott Libre Rio for adults aged 18 years and older with type 2 diabetes. The OTC CGM is designed for adults who do not use insulin and who

SAN FRANCISCO — Effective strategies to prevent and manage hypertensive disorders of pregnancy are often underutilized, but a new CDC initiative aims to harness solutions that work and package them in one place for busy clinicians.The CDC's National Center for Chronic Disease Prevention and Health Promotion released a Hypertension in Pregnancy Change Package, developed in partnership with

BALTIMORE — Adults with type 1 diabetes experience diabetes distress even with the use of continuous glucose monitoring, according to findings presented at the Association of Diabetes Care & Educational Specialists Annual Conference. “One of the benefits of CGM is that it helps to streamline diabetes management, which may help to make daily diabetes management easier,”

The North American Menopause Society released its 2023 Nonhormone Therapy Position Statement recommending up-to-date scientific evidence for nonhormonal options for managing menopausal symptoms.The 2023 position statement is an update to the Nonhormonal Management of Menopause-Associated Vasomotor Symptoms 2015 Position Statement and has been published in Menopause.

The FDA is advising people using semaglutide to avoid some compounded formulations due to the use of ingredients that may cause adverse events, according to a safety notice. As of May, semaglutide (Ozempic/Wegovy, Novo Nordisk) appears on the FDA’s drug shortages list. According to the notice, compounded versions of drugs on the shortage list can be prepared if they meet certain